<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29232" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Somogyi Phenomenon</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Reyhanoglu</surname>
            <given-names>Gizem</given-names>
          </name>
          <aff>LECOM</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rehman</surname>
            <given-names>Anis</given-names>
          </name>
          <aff>District Endocrine/Sentara Northern Virginia Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Gizem Reyhanoglu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anis Rehman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29232.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">The Somogyi effect, also known as the "chronic Somogyi rebound" or "posthypoglycemic hyperglycemia," was a theory proposed in the 1930s by Dr. Michael Somogyi, a Hungarian-born professor at Washington University, St. Louis, MO, United States.<xref ref-type="bibr" rid="article-29232.r1">[1]</xref>&#x000a0;He described the paradoxical tendency of the body to react to hypoglycemia by producing hyperglycemia. Somogyi&#x000a0;proposed that when blood glucose levels drop too low during the late evening, activation of counterregulatory hormones such as adrenaline, corticosteroids, growth hormone, and glucagon may be observed, leading to activation of gluconeogenesis and resultant hyperglycemia in the early morning.<xref ref-type="bibr" rid="article-29232.r2">[2]</xref></p>
        <p>However, more recent studies involving continuous glucose monitoring (CGM) have disputed this theory. Also, clinicians have observed that patients with early morning hyperglycemia tend to have high blood glucose measurements at night rather than low.<xref ref-type="bibr" rid="article-29232.r1">[1]</xref>&#x000a0;As a result, the debate continues in the scientific community regarding Somogyi's theory. Moreover, recently proposed mechanisms of morning hyperglycemia include nocturnal growth hormone secretion, hypoinsulinemia, and insulin resistance associated with metabolic syndrome.<xref ref-type="bibr" rid="article-29232.r3">[3]</xref></p>
      </sec>
      <sec id="article-29232.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>
<bold>Somogyi Phenomenon vs. Dawn Phenomenon</bold>
</p>
        <p>A phenomenon known as the dawn phenomenon was introduced by Dr. Schimdt in the 1980s, stating that morning hyperglycemia is due to the decreased levels of endogenous insulin secreted at night.<xref ref-type="bibr" rid="article-29232.r1">[1]</xref>&#x000a0;The dawn phenomenon also contributes to morning hyperglycemia to increased concentrations of insulin-antagonist hormones. The dawn phenomenon is comparable to the Somogyi phenomenon, which attributes morning hyperglycemia to counterregulatory hormones from low glucose. The dawn phenomenon has been noted to occur more commonly than the Somogyi phenomenon.<xref ref-type="bibr" rid="article-29232.r1">[1]</xref>&#x000a0;While the two theories are not seen in all cases of insulin-dependent diabetics, it is important to note that the best way to prevent either is optimal diabetes control with the proper insulin therapy.<xref ref-type="bibr" rid="article-29232.r1">[1]</xref></p>
        <p>The Somogyi phenomenon states that early morning hyperglycemia occurs due to a rebound effect from late-night hypoglycemia. However, the dawn phenomenon does not include hypoglycemic episodes to be a factor.</p>
        <p>
<bold>Insulin Release and Insulin Resistance</bold>
</p>
        <p>With recent studies attributing early morning hyperglycemia to hypoinsulinemia,&#x000a0;there is an observable pattern&#x000a0;in which the body secretes insulin. The theory is insulin gets secreted in a circadian pattern, with the lowest concentrations between midnight and 6 AM and the highest concentrations between noon and 6 PM.<xref ref-type="bibr" rid="article-29232.r4">[4]</xref>&#x000a0;This pattern of insulin secretion is the opposite of melatonin from the pineal gland. The circadian pattern of insulin secretion provides evidence for the dawn phenomenon.</p>
        <p>The Somogyi phenomenon has been a proposed phenomenon in insulin-dependent diabetic patients. The thinking is that these patients should&#x000a0;monitor their blood glucose levels and adjust insulin dosages as necessary to prevent hypo- or hyperglycemic episodes.</p>
        <p>In an individual that does not have diabetes, the blood glucose and insulin concentrations stay flat and constant throughout the night, with a transient increase in insulin just before dawn to prevent hepatic glucose production through gluconeogenesis and prevent hyperglycemia.<xref ref-type="bibr" rid="article-29232.r5">[5]</xref>&#x000a0;This explains why non-diabetic patients do not exhibit the dawn phenomenon, as their insulin levels follow the circadian pattern necessary for optimal glucose control.</p>
        <p>Insulin resistance, seen in diabetes or metabolic syndrome, has been associated with constant exposure to high insulin levels.<xref ref-type="bibr" rid="article-29232.r6">[6]</xref>&#x000a0;As patients get diagnosed with diabetes or metabolic syndrome at an earlier age, there is more exogenous insulin exposure that leads to this resistance. Because of this, the normal regulation and pattern of insulin levels make it difficult for insulin-dependent diabetics to control their blood glucose levels during their sleep.&#x000a0;Not only is insulin necessary to regulate glucose levels, but it is also the primary hormone that inhibits gluconeogenesis.<xref ref-type="bibr" rid="article-29232.r7">[7]</xref>&#x000a0;Gluconeogenesis in the morning gets inhibited in a non-diabetic due to the transient increase in insulin right before dawn. As a patient becomes more and more resistant to insulin, the key inhibitor of gluconeogenesis is no longer working; this allows the body to produce more glucose, leading to a hyperglycemic state.</p>
      </sec>
      <sec id="article-29232.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The Somogyi phenomenon&#x000a0;had been considered in the past; an&#x000a0;essential&#x000a0;consideration for the proper diagnosis and management of blood glucose levels is vital for the body&#x02019;s metabolic demands. The post-hypoglycemic hyperglycemia raises the question of whether a patient&#x02019;s insulin levels should be adjusted in the evening to prevent hyperglycemia in the morning. As this is something ideally avoided, the Somogyi phenomenon occurs too infrequently to make this standardized practice.</p>
        <p>
<bold>Hypoglycemia vs. Hyperglycemia</bold>
</p>
        <p>Glucose control is vital for brain metabolism and function, as it is the primary substrate for proper brain activity. The body has different regulatory molecules that act to decrease the likelihood of low blood glucose. The first response thought to activate due to low blood glucose is the counterregulatory hormone mechanism.<xref ref-type="bibr" rid="article-29232.r8">[8]</xref>&#x000a0;Other mechanisms include glycogenolysis, the breakdown of glycogen into glucose, and gluconeogenesis,&#x000a0;<italic toggle="yes">de novo</italic>&#x000a0;production of glucose, which occur in the liver.<xref ref-type="bibr" rid="article-29232.r7">[7]</xref>&#x000a0;The ideal plasma glucose concentration ranges from 70&#x000a0;to 140 mg/dL throughout the day.<xref ref-type="bibr" rid="article-29232.r9">[9]</xref>&#x000a0;Both glycogenolysis and gluconeogenesis can activate when levels fall below this range. Another mechanism induced by hypoglycemia includes a decrease in the pancreatic beta-cell secretion of insulin and an increase in the pancreatic alpha-cell secretion of glucagon. Glucagon, epinephrine, and glucocorticoid production will increase to induce glucose production in the body.<xref ref-type="bibr" rid="article-29232.r10">[10]</xref>&#x000a0;A hypoglycemic episode puts patients at risk for neurological dysfunction, coma, or even death.<xref ref-type="bibr" rid="article-29232.r10">[10]</xref>&#x000a0;With repeated hypoglycemia, the counterregulatory system that is supposed to keep blood glucose levels in range will start to fail.<xref ref-type="bibr" rid="article-29232.r10">[10]</xref>&#x000a0;Signs of hypoglycemia that patients must be aware of include diaphoresis, hunger, irritability, loss of consciousness, seizures, and confusion.<xref ref-type="bibr" rid="article-29232.r10">[10]</xref></p>
        <p>Hyperglycemic episodes are also to be avoided. Symptoms to look out for include polyuria, polydipsia, weakness, tachycardia, and hypotension.<xref ref-type="bibr" rid="article-29232.r11">[11]</xref>&#x000a0;The hyperglycemia will worsen the cytokine and inflammatory response, causing even more hyperglycemia.<xref ref-type="bibr" rid="article-29232.r11">[11]</xref>&#x000a0;Consequences of hyperglycemia include renal failure, polyneuropathy, retinopathy, and arrhythmias.<xref ref-type="bibr" rid="article-29232.r11">[11]</xref>&#x000a0;Hyperglycemia produces an increase in advanced glycation end products (AGEs), which deposit in the body, causing connective tissue crosslinking, fibrosis, and impaired relaxation of the heart.<xref ref-type="bibr" rid="article-29232.r12">[12]</xref>&#x000a0;People with diabetes become insulin-resistant, which keeps blood glucose levels elevated, causing an even more increase in AGEs.<xref ref-type="bibr" rid="article-29232.r12">[12]</xref>&#x000a0;With the failure to keep blood glucose levels at a normal range, the hyperglycemic episodes also induce the renin-angiotensin-aldosterone system (RAAS), increasing vascular resistance and arterial pressure in the body.<xref ref-type="bibr" rid="article-29232.r12">[12]</xref></p>
        <p>In an interprofessional team, there are many things to consider in managing a patient&#x02019;s blood glucose concentrations. Theoretically, the risks of adjusting a patient&#x02019;s insulin in case they undergo the Somogyi phenomenon could risk the potential consequence of increasing a patient&#x02019;s chance of becoming severely hypoglycemic.&#x000a0;</p>
        <p>It is essential to coordinate care by involving the patient in discussions regarding proper glucose management. Lifestyle modifications and being aware of the symptoms of hypoglycemia or hyperglycemia require discussion in great detail with the patient. It will allow them to make well-informed decisions regarding their food choices, lifestyle habits, and activity levels.</p>
        <p>
<bold>Controversy</bold>
</p>
        <p>The importance of maintaining proper blood glucose levels in any patient is apparent from both ends of blood glucose level abnormalities. Using the Somogyi phenomenon as a precaution for standard in practice does not have enough evidence. Instead, this theory can be used to help monitor patients&#x02019; blood glucose levels throughout different times of the day to see if they fit the theory.</p>
        <p>Clinical studies suggest that underdosing of insulin from the previous night fails to prevent hyperglycemia.<xref ref-type="bibr" rid="article-29232.r2">[2]</xref> Another study on Type 1 Diabetes patients suggested that nocturnal hypoglycemia is usually associated with early morning hypoglycemia, not hyperglycemia.<xref ref-type="bibr" rid="article-29232.r13">[13]</xref>&#x000a0;In clinical practice, patients with hypoglycemic episodes at night do not wake up in the morning with hyperglycemia, hence refuting Somogyi Phenomenon.&#x000a0;</p>
        <p>In a study done at the Washington University School of Medicine to test the hypothesis of the Somogyi phenomenon, the conclusion was that the nocturnal hypoglycemia did not cause daytime hyperglycemia.<xref ref-type="bibr" rid="article-29232.r14">[14]</xref>&#x000a0;It showed no correlation between increased daytime glucose levels with the concentrations of counterregulatory hormones such as glucagon, epinephrine, growth hormone, or cortisol.<xref ref-type="bibr" rid="article-29232.r14">[14]</xref>&#x000a0;This study disproved the theory of Dr. Somogyi.&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-29232.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>All interprofessional healthcare team members who interact with patients with diabetes should be aware of the Somogyi phenomenon and the dawn effect and be able to explain them to their patients if it comes up&#x000a0;during patient counseling, as patients may have heard of it and ask questions. Interprofessional healthcare team members can explain that it is no longer considered valid and direct the patients toward more scientifically back resources to help manage their condition.</p>
      </sec>
      <sec id="article-29232.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29232&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29232">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29232/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29232">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-29232.s6">
        <fig id="article-29232.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Somogyi effect Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Somogyi__effect" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-29232.s7">
        <fig id="article-29232.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Dawn phenomenon Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Dawn__phenomenon1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-29232.s8">
        <title>References</title>
        <ref id="article-29232.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rybicka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Krysiak</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Okopie&#x00144;</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>The dawn phenomenon and the Somogyi effect - two phenomena of morning hyperglycaemia.</article-title>
            <source>Endokrynol Pol</source>
            <year>2011</year>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>276</fpage>
            <page-range>276-84</page-range>
            <pub-id pub-id-type="pmid">21717414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gale</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Kurtz</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Tattersall</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>In search of the Somogyi effect.</article-title>
            <source>Lancet</source>
            <year>1980</year>
            <month>Aug</month>
            <day>09</day>
            <volume>2</volume>
            <issue>8189</issue>
            <fpage>279</fpage>
            <page-range>279-82</page-range>
            <pub-id pub-id-type="pmid">6105438</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raskin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The Somogyi phenomenon. Sacred cow or bull?</article-title>
            <source>Arch Intern Med</source>
            <year>1984</year>
            <month>Apr</month>
            <volume>144</volume>
            <issue>4</issue>
            <fpage>781</fpage>
            <page-range>781-7</page-range>
            <pub-id pub-id-type="pmid">6370162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boden</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Urbain</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Evidence for a circadian rhythm of insulin secretion.</article-title>
            <source>Am J Physiol</source>
            <year>1996</year>
            <month>Aug</month>
            <volume>271</volume>
            <issue>2 Pt 1</issue>
            <fpage>E246</fpage>
            <page-range>E246-52</page-range>
            <pub-id pub-id-type="pmid">8770017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porcellati</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lucidi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bolli</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Fanelli</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes.</article-title>
            <source>Diabetes Care</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>36</volume>
            <issue>12</issue>
            <fpage>3860</fpage>
            <page-range>3860-2</page-range>
            <pub-id pub-id-type="pmid">24265365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shanik</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Skrha</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dankner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zick</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Roth</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?</article-title>
            <source>Diabetes Care</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>31 Suppl 2</volume>
            <fpage>S262</fpage>
            <page-range>S262-8</page-range>
            <pub-id pub-id-type="pmid">18227495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hatting</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tavares</surname>
                <given-names>CDJ</given-names>
              </name>
              <name>
                <surname>Sharabi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rines</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Puigserver</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Insulin regulation of gluconeogenesis.</article-title>
            <source>Ann N Y Acad Sci</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>1411</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-35</page-range>
            <pub-id pub-id-type="pmid">28868790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolli</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Fanelli</surname>
                <given-names>CG</given-names>
              </name>
            </person-group>
            <article-title>Physiology of glucose counterregulation to hypoglycemia.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>1999</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>3</issue>
            <fpage>467</fpage>
            <page-range>467-93, v</page-range>
            <pub-id pub-id-type="pmid">10500926</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Chacko</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Sunehag</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Haymond</surname>
                <given-names>MW</given-names>
              </name>
            </person-group>
            <article-title>Measurements of Gluconeogenesis and Glycogenolysis: A Methodological Review.</article-title>
            <source>Diabetes</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>64</volume>
            <issue>12</issue>
            <fpage>3996</fpage>
            <page-range>3996-4010</page-range>
            <pub-id pub-id-type="pmid">26604176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kalra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Venkataraman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bantwal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Saboo</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ramachandran</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hypoglycemia: The neglected complication.</article-title>
            <source>Indian J Endocrinol Metab</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>5</issue>
            <fpage>819</fpage>
            <page-range>819-34</page-range>
            <pub-id pub-id-type="pmid">24083163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dungan</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Braithwaite</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Preiser</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Stress hyperglycaemia.</article-title>
            <source>Lancet</source>
            <year>2009</year>
            <month>May</month>
            <day>23</day>
            <volume>373</volume>
            <issue>9677</issue>
            <fpage>1798</fpage>
            <page-range>1798-807</page-range>
            <pub-id pub-id-type="pmid">19465235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Whaley-Connell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sowers</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.</article-title>
            <source>Diabetologia</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>61</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-28</page-range>
            <pub-id pub-id-type="pmid">28776083</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guillod</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Comte-Perret</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Monbaron</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gaillard</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Nocturnal hypoglycaemias in type 1 diabetic patients: what can we learn with continuous glucose monitoring?</article-title>
            <source>Diabetes Metab</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>360</fpage>
            <page-range>360-5</page-range>
            <pub-id pub-id-type="pmid">17652003</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29232.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hirsch</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Havlin</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Clutter</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>Cryer</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Failure of nocturnal hypoglycemia to cause daytime hyperglycemia in patients with IDDM.</article-title>
            <source>Diabetes Care</source>
            <year>1990</year>
            <month>Feb</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>133</fpage>
            <page-range>133-42</page-range>
            <pub-id pub-id-type="pmid">2190769</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
